McBride Dennis
SEC insider (Form 3/4/5 filer). CIK 0002028250. Director at NRX Pharmaceuticals, Inc. (NRXP). 1 reported Form 4/5 transaction since Sep 2024; latest on Apr 9, 2025. Located in WILMINGTON, DE.
Companies McBride Dennis has filed insider reports for
- NRX Pharmaceuticals, Inc. (NRXP): Director
McBride Dennis
CIK: 0002028250
Transaction Breakdown
Open Market Buys (P)0 (0.0%)
High conviction signal
Open Market Sales (S)0 (0.0%)
Position reduction
Option Exercises (M)0 (0.0%)
Derivative conversions
Awards (A)1 (100.0%)
Compensation grants
Other (G, F, J, C, D, …)0 (0.0%)
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
NRXP
NRX Pharmaceuticals, Inc.
Director